Adcock Ingram, South Africa's second-biggest pharmaceutical company, is actively looking for acquisition opportunities in Africa, the Moneyweb news portal reported. We want to make sure that whatever we do is easily transactable and accretive to our shareholders as quickly as possible, the company's CEO, Jonathan Louw, told the portal. According to the executive, the company looks for opportunities both in Africa and the rest of the world but at present is focused mostly on the rest of Africa. Last year, Adcock acquired just over 65% in Ghanaian pharmaceutical company Ayrton Drug Manufacturing for an undisclosed sum. The company's turnover increased by 14% to ZAR 2.2bn in the six months ended March 31, 2011. |
South African company Exxaro Resources said one of the options it currently considers is dismissing striking coal mine workers who fail to return to work in the week of March 25, fin24 reported ... more
South Africas telecommunication operator Telkom said that it has not made a decision on retrenching 13,000 employees, or more than half of its staff, TechCentral reported quoting a company ... more
Oryx Energies, a major independent provider of oil and gas products and services in Africa, has agreed to buy the South African liquefied petroleum gas (LPG) distribution businesses of BP and ... more